Advertisement
Screener

ANAVEX LIFE SCIENCES CORP. (AVXL) Debt Components

ANAVEX LIFE SCIENCES CORP. (AVXL) Debt Components

  • 2016-09-30: Notes Payable, CurrentUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-term Debt, GrossUSD (m).
  • 2016-06-30: Notes Payable, CurrentUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-term Debt, GrossUSD (m).
  • 2016-06-30: Notes Payable, CurrentUSD $87.89K; Long-term Debt, Excluding Current MaturitiesUSD $345.00; Long-term DebtUSD (m); Long-term Debt, GrossUSD (m).
  • 2016-03-31: Notes Payable, CurrentUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-term Debt, GrossUSD (m).

ANAVEX LIFE SCIENCES CORP. Debt Components

Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.

Period endNotes Payable, Current
USD
Long-term Debt, Excluding Current Maturities
USD
Long-term Debt
USD
Long-term Debt, Gross
USD
Debt Instrument, Face Amount
USD
Debt Instrument, Convertible, Number of Equity Instruments
N
Debt Instrument, Convertible, Number of Equity Instruments
Number
Debt Instrument, Convertible, Beneficial Conversion Feature
USD
Debt Instrument, Convertible, Conversion Price
USD/shares
Debt Instrument, Unamortized Discount
USD
2016-09-30(m)(m)(m)(m)(m)(m)(m)(m)1.00(m)
2016-06-30(m)(m)(m)(m)(m)9 month · 1.16K(m)9 month · $1.16K(m)(m)
2016-06-30$87.89K$345.00(m)(m)(m)(m)(m)(m)1.00(m)
2016-03-31(m)(m)(m)(m)(m)6 month · 1.16K(m)6 month · $1.16K(m)(m)
2016-03-31$88.14K$337.00(m)(m)(m)(m)(m)(m)1.00(m)
2015-12-31(m)(m)(m)(m)(m)(m)(m)3 month · $1.16K(m)(m)
2015-12-31(m)(m)(m)(m)(m)(m)(m)(m)1.00(m)
2015-12-31(m)(m)(m)(m)(m)3 month · 1.16K(m)(m)(m)(m)
2015-12-31$82.41K$265.00$265.00$265.00$4.98K(m)(m)(m)(m)$4.72K
2015-09-30(m)(m)(m)(m)(m)(m)12 month · 7.27M12 month · $7.44M(m)(m)
2015-09-30(m)(m)(m)(m)(m)(m)(m)(m)1.00(m)
2015-09-30$85.24K$332.00$332.00$332.00$6.16K(m)(m)(m)(m)$5.83K
2015-09-30(m)(m)(m)(m)(m)12 month · 7.27M(m)(m)(m)(m)
2015-06-30(m)(m)(m)(m)(m)9 month · 5.81M(m)(m)(m)(m)
2015-06-30(m)(m)(m)(m)(m)(m)(m)(m)1.00(m)
2015-06-30$92.52K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-03-31(m)(m)(m)(m)(m)6 month · 3.92M(m)(m)(m)(m)
2015-03-31(m)(m)(m)(m)(m)(m)(m)(m)1.00(m)
2015-03-31$90.41K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-12-31(m)(m)(m)(m)(m)3 month · 1.40M(m)(m)(m)(m)
2014-12-31(m)(m)(m)(m)(m)(m)(m)(m)1.00(m)
2014-12-31$98.31K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-09-30(m)(m)(m)(m)(m)(m)12 month · 1.59M12 month · $1.91M(m)(m)
2014-09-30(m)(m)(m)(m)(m)(m)(m)(m)1.20(m)
2014-09-30(m)(m)(m)(m)(m)12 month · 1.59M(m)(m)(m)(m)
2014-09-30$192.06K$5.72M$5.72M$263.73K$7.45M(m)(m)(m)(m)$7.18M
2014-06-30$200.84K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-03-31$193.72K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-12-31$200.36K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-09-30$210.86K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-06-30$757.60K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-03-31$761.29K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-12-31$599.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-09-30$299.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-06-30$49.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-03-31$1.20M(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-12-31$1.16M(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-09-30$867.92K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-06-30$827.90K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-09-30$2.49M(m)(m)(m)(m)(m)(m)(m)(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
Alector, Inc. (ALEC)United States$0.213B-1.90
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95